49662 Federal Register / Vol. 70, No. 163 / Wednesday, August 24, 2005 / Notices 

Division of Medicine and Dentistry, Health 

Resources and Services Administration, and 

remarks have been invited from the Bureau 

of Health Professions and the Agency. A 

plenary session will follow in which 

speakers will address the Advisory 

Committee on the topic of health-outcomes 

disparities in at-risk populations and the 

interface of Title VII, section 747 training 

programs with community groups to enhance 

care for vulnerable populations. In plenary 

session and in small workgroups, the 

Advisory Committee will make plans for the 

report. There also will be annual elections for 

a new chair and two vice chairs. An 

opportunity will be provided for public 

comment. 

On Friday, September 30, the Advisory 

Committee will open its meeting with an 

address on the topic of a theoretical 

framework for understanding vulnerability as 

it relates to individual patients and patient 

populations. The Advisory Committee will 

continue work on the sixth report and select 

members to serve on a Writing Group whose 

members will guide the report preparation 

process. An opportunity will be provided for 

public comment. 

For Further Information Contact: Anyone 

interested in obtaining a roster of members or 

other relevant information should write or 

contact Jerilyn K. Glass, M.D., Ph.D., Division 

of Medicine and Dentistry, Bureau of Health 

Professions, Health Resources and Services 

Administration, Room 9A–27, Parklawn 

Building, 5600 Fishers Lane, Rockville, 

Maryland 20857, Telephone (301) 443–6785. 

The Web address for information on the 

Advisory Committee is http://bhpr.hrsa.gov/

medicine-dentistry/actpcmd.

Dated: August 17, 2005. 

Tina M. Cheatham, 

Director, Division of Policy Review and 

Coordination.

[FR Doc. 05–16788 Filed 8–23–05; 8:45 am] 

BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Clinical Center; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the NIH 

Advisory Board for Clinical Research. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting.

Name of Committee: NIH Advisory Board 

for Clinical Research. 

Date: September 23, 2005. 

Time: 10 a.m. to 2 p.m. 

Agenda: To discuss progress of activities 

related to research opportunities, training, 

planning and funding in the NIH intramural 

clinical research program. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, CRC Medical 

Board Room 4–2551, Bethesda, MD 20892. 

Contact Person: Maureen E. Gormley, 

Executive Secretary, Mark O. Hatfield 

Clinical Research Center, National Institutes 

of Health, Building 10, Room 6–1610, 

Bethesda, MD 20892, 301/496–2897. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by non-government 

employees. Persons without a government 

I.D. will need to show a photo I.D. and signin at the security desk upon entering the 

building.

Dated: August 17, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–16757 Filed 8–23–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of meetings of the 

National Advisory Neurological 

Disorders and Stroke Council. 

The meetings will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Advisory 

Neurological Disorders and Stroke Council, 

Training, Career Development, and Special 

Programs Subcommittee. 

Date: September 14, 2005. 

Open: 8 p.m. to 9:30 p.m. 

Agenda: To discuss the training programs 

of the Institute. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814.

Closed: 9:30 p.m. to 10 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Margaret Jacobs, Acting 

Training and Special Programs Officer, 

National Institute of Neurological Disorders 

and Stroke, National Institutes of Health, 

6001 Executive Blvd., Suite 2154 MSC 9527, 

Bethesda, MD 20892–9527, 301–496–4188, 

mj22o@nih.gov.

Name of Committee: National Advisory 

Neurological Disorders and Stroke Council, 

Clinical Trials Subcommittee. 

Date: September 15, 2005. 

Open: 8 a.m. to 9 a.m. 

Agenda: To discuss clinical trials policy. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C Wing, 

Conference Room 6, Bethesda, MD 20892.

Closed: 9 a.m. to 10 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C Wing, 

Conference Room 6, Bethesda, MD 20892. 

Contact Person: John Marler, MD, 

Associate Director for Clinical Trials, 

National Institute of Neurological Disorders 

and Stroke, National Institutes of Health, 

6001 Executive Blvd., Suite 2216, Bethesda, 

MD 20892, (301) 496–9135, 

jm137f@niah.gov.

Name of Committee: National Advisory 

Neurological Disorders and Stroke Council, 

Basic and Preclinical Programs 

Subcommittee. 

Date: September 15, 2005. 

Open: 8 a.m. to 10 a.m. 

Agenda: To discuss basic and preclinical 

programs policy. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, A Wing, 

Conference Room 8A–28, Bethesda, MD 

20892. 

Contact Person: Robert Baughman, MD, 

Associate Director for Technology 

Development, National Institute of 

Neurological Disorders and Stroke, National 

Institutes of Health, 6001 Executive Blvd., 

Suite 2137, MSC 9527, Bethesda, MD 20892–

9527, (301) 496–1779. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by non-government 

employees. Persons without a government 

I.D. will need to show a photo I.D. and signin at the security desk upon entering the 

building. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.ninds.nih.gov, where an agenda and 

any additional information for the meeting 

will be posted when available.